Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Association between HRAS rs12628 and rs112587690 polymorphisms with the risk of melanoma in the North American population.

Tomei S, Adams S, Uccellini L, Bedognetti D, De Giorgi V, Erdenebileg N, Ascierto ML, Reinboth J, Liu Q, Bevilacqua G, Wang E, Mazzanti C, Marincola FM.

Med Oncol. 2012 Dec;29(5):3456-61. doi: 10.1007/s12032-012-0255-3. Epub 2012 May 22.

2.

Lack of mutational events of RAS genes in sporadic thyroid cancer but high risk associated with HRAS T81C single nucleotide polymorphism (case-control study).

Khan MS, Pandith AA, Ul Hussain M, Iqbal M, Khan NP, Wani KA, Masoodi SR, Mudassar S.

Tumour Biol. 2013 Feb;34(1):521-9. doi: 10.1007/s13277-012-0577-y. Epub 2012 Nov 13.

PMID:
23150177
3.

HRAS T81C polymorphism modulates risk of urinary bladder cancer and predicts advanced tumors in ethnic Kashmiri population.

Pandith AA, Shah ZA, Khan NP, Baba KM, Wani MS, Siddiqi MA.

Urol Oncol. 2013 May;31(4):487-92. doi: 10.1016/j.urolonc.2011.03.004. Epub 2011 Apr 21.

PMID:
21514184
4.

Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study.

Blankenburg S, König IR, Moessner R, Laspe P, Thoms KM, Krueger U, Khan SG, Westphal G, Berking C, Volkenandt M, Reich K, Neumann C, Ziegler A, Kraemer KH, Emmert S.

Carcinogenesis. 2005 Jun;26(6):1085-90. Epub 2005 Feb 24.

PMID:
15731165
5.

Distal and proximal interleukin (IL)-10 promoter polymorphisms associated with risk of cutaneous melanoma development: a case--control study.

Schoof N, von Bonin F, König IR, Mössner R, Krüger U, Reich K, Berking C, Volkenandt M, Ziegler A, Böckmann L, Kuschal C, Thoms KM, Kube D, Emmert S.

Genes Immun. 2009 Sep;10(6):586-90. doi: 10.1038/gene.2009.40. Epub 2009 May 21.

PMID:
19458621
6.

Genetic analysis of H-ras intron-1 polymorphic and variable tandem repeat regions in human breast cancer.

Papadakis EN, Dokianakis DN, Spandidos DA.

Int J Biol Markers. 2003 Jul-Sep;18(3):195-9.

PMID:
14535590
7.

Single-nucleotide polymorphisms in genes encoding toll-like receptor -2, -3, -4, and -9 in a case-control study with bladder cancer susceptibility in a North Indian population.

Singh V, Srivastava N, Kapoor R, Mittal RD.

Arch Med Res. 2013 Jan;44(1):54-61. doi: 10.1016/j.arcmed.2012.10.008. Epub 2012 Nov 6.

PMID:
23142523
8.

Polymorphisms of the neuronal and inducible nitric oxide synthase genes and the risk of cutaneous melanoma: a case-control study.

Li C, Hu Z, Liu Z, Wang LE, Gershenwald JE, Lee JE, Prieto VG, Duvic M, Grimm EA, Wei Q.

Cancer. 2007 Apr 15;109(8):1570-8.

9.

Promoter polymorphisms in matrix metallopeptidase 1 and risk of cutaneous melanoma.

Wang LE, Huang YJ, Yin M, Gershenwald JE, Prieto VG, Lee JE, Duvic M, Grimm EA, Wei Q.

Eur J Cancer. 2011 Jan;47(1):107-15. doi: 10.1016/j.ejca.2010.06.129. Epub 2010 Jul 23.

10.

Association between H-RAS T81C genetic polymorphism and gastrointestinal cancer risk: a population based case-control study in China.

Zhang Y, Jin M, Liu B, Ma X, Yao K, Li Q, Chen K.

BMC Cancer. 2008 Sep 10;8:256. doi: 10.1186/1471-2407-8-256.

11.

Melanoma risk is associated with vitamin D receptor gene polymorphisms.

Zeljic K, Kandolf-Sekulovic L, Supic G, Pejovic J, Novakovic M, Mijuskovic Z, Magic Z.

Melanoma Res. 2014 Jun;24(3):273-9. doi: 10.1097/CMR.0000000000000065.

PMID:
24638155
12.

European ancestry and polymorphisms in DNA repair genes modify the risk of melanoma: a case-control study in a high UV index region in Brazil.

Gonçalves FT, Francisco G, de Souza SP, Luiz OC, Festa-Neto C, Sanches JA, Chammas R, Gattas GJ, Eluf-Neto J.

J Dermatol Sci. 2011 Oct;64(1):59-66. doi: 10.1016/j.jdermsci.2011.06.003. Epub 2011 Jun 17.

PMID:
21733660
13.

No Evidence for BRAF as a melanoma/nevus susceptibility gene.

Jackson S, Harland M, Turner F, Taylor C, Chambers PA, Randerson-Moor J, Swerdlow AJ, dos Santos Silva I, Beswick S, Bishop DT, Newton Bishop JA.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):913-8.

14.

BRAF, NRAS and HRAS mutations in spitzoid tumours and their possible pathogenetic significance.

Da Forno PD, Pringle JH, Fletcher A, Bamford M, Su L, Potter L, Saldanha G.

Br J Dermatol. 2009 Aug;161(2):364-72. doi: 10.1111/j.1365-2133.2009.09181.x. Epub 2009 Apr 29.

15.

High risk of cutaneous melanoma amongst carriers of the intercellular adhesion molecule-1 R241 allele.

Vinceti M, Pellacani G, Casali B, Malagoli C, Nicoli D, Farnetti E, Bassissi S, Bergomi M, Seidenari S.

Melanoma Res. 2006 Feb;16(1):93-6.

PMID:
16432463
16.

Long telomere length and a TERT-CLPTM1 locus polymorphism association with melanoma risk.

Llorca-Cardeñosa MJ, Peña-Chilet M, Mayor M, Gomez-Fernandez C, Casado B, Martin-Gonzalez M, Carretero G, Lluch A, Martinez-Cadenas C, Ibarrola-Villava M, Ribas G.

Eur J Cancer. 2014 Dec;50(18):3168-77. doi: 10.1016/j.ejca.2014.09.017. Epub 2014 Oct 31.

PMID:
25457634
17.

Variants of the xeroderma pigmentosum variant gene (POLH) are associated with melanoma risk.

Di Lucca J, Guedj M, Lacapère JJ, Fargnoli MC, Bourillon A, Dieudé P, Dupin N, Wolkenstein P, Aegerter P, Saiag P, Descamps V, Lebbe C, Basset-Seguin N, Peris K, Grandchamp B, Soufir N.

Eur J Cancer. 2009 Dec;45(18):3228-36. doi: 10.1016/j.ejca.2009.04.034. Epub 2009 May 26.

PMID:
19477635
18.

Genetic variation at KIT locus may predispose to melanoma.

Bourillon A, Hu HH, Hetet G, Lacapere JJ, André J, Descamps V, Basset-Seguin N, Ogbah Z, Puig S, Saiag P, Bagot M, Bensussan A, Grandchamp B, Dumaz N, Soufir N.

Pigment Cell Melanoma Res. 2013 Jan;26(1):88-96. doi: 10.1111/pcmr.12032. Epub 2012 Nov 23.

PMID:
23020152
19.

Genome-wide association study identifies nidogen 1 (NID1) as a susceptibility locus to cutaneous nevi and melanoma risk.

Nan H, Xu M, Zhang J, Zhang M, Kraft P, Qureshi AA, Chen C, Guo Q, Hu FB, Rimm EB, Curhan G, Song Y, Amos CI, Wang LE, Lee JE, Wei Q, Hunter DJ, Han J.

Hum Mol Genet. 2011 Jul 1;20(13):2673-9. doi: 10.1093/hmg/ddr154. Epub 2011 Apr 9.

20.

Genetic polymorphisms in DNA repair and oxidative stress pathways associated with malignant melanoma susceptibility.

Ibarrola-Villava M, Peña-Chilet M, Fernandez LP, Aviles JA, Mayor M, Martin-Gonzalez M, Gomez-Fernandez C, Casado B, Lazaro P, Lluch A, Benitez J, Lozoya R, Boldo E, Pizarro A, Martinez-Cadenas C, Ribas G.

Eur J Cancer. 2011 Nov;47(17):2618-25. doi: 10.1016/j.ejca.2011.05.011. Epub 2011 Jun 9.

PMID:
21641795

Supplemental Content

Support Center